Global Epidermolysis Bullosa Care and Treatment Market: Market Research by Knowledge Sourcing Intelligence
The global Epidermolysis Bullosa market is projected to grow from US$1,313.346 million in 2017 to US$1,644.712 million in 2022, at a compound annual growth rate (CAGR) of 4.60% over the forecast period. Rising expenditure on the treatment of EB and research activities is further propelling the growth of Epidermolysis Bullosa Care and Treatment market. Owing to the increased cases of patients suffering from EB, international organizations, as well as international and domestic banks and financial institutions, are funding global healthcare and pharmaceutical companies to continue the R&D processes for the development of cures and treatments for orphan and rare diseases. In October 2016, the U.S. Food and Drug Administration (FDA) awarded 21 new clinical trial research grants through the Orphan Products Clinical Trials Grants Program. The grant, of more than US$23 million, was awarded to principal investigators from academia and industry for the next four years to promote earl...